William Blair Initiates Coverage of Exact Sciences

The investment firm noted the "enormous" market opportunity for Exact Sciences' Cologuard test and predicted it would receive FDA clearance in 2013.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.